Welcome to our dedicated page for Carecloud SEC filings (Ticker: CCLDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings associated with CareCloud, Inc. and the preferred stock context of CCLDP provide detailed insight into the company’s regulatory disclosures, capital structure, acquisitions, and financing arrangements. Through forms such as Form 8-K, investors can review material events that affect CareCloud’s common and preferred equity, including its 8.75% Series A and Series B Cumulative Redeemable Perpetual Preferred Stock.
Recent 8-K filings describe a range of corporate actions. These include the mandatory conversion of the Series A Preferred Stock into common stock and the resulting delisting of the Series A Preferred Stock from the Nasdaq Global Market, which is directly relevant to the historical CCLDP preferred security. Other filings detail dividend declarations for Series A and Series B Preferred Stock, a plan to pay double monthly dividends on Series B Preferred Stock to address accumulated dividend arrears, and the terms under which the company may redeem Series B Preferred Stock at specified prices plus accumulated and unpaid dividends.
CareCloud’s filings also cover acquisitions and strategic transactions, such as the Asset Purchase Agreement through which a newly created indirect subsidiary acquired certain assets of Medsphere Systems Corporation, a provider of healthcare IT software and related services to the U.S. inpatient and ambulatory market. The company discloses the purchase price structure, deferred payment agreement with a bank lender, and related security agreements. Additional 8-Ks report on the acquisition of HFMA’s MAP App, changes in the company’s independent registered public accounting firm, termination of a prior secured revolving line of credit, and entry into a new line of credit agreement secured by substantially all of the company’s assets.
On this page, investors can access CareCloud’s annual reports (Form 10-K), quarterly reports (Form 10-Q), and current reports (Form 8-K) as they become available from EDGAR, along with any proxy statements and registration statements that relate to its securities. Stock Titan’s tools can surface key points from lengthy filings, helping users quickly understand topics such as revenue trends, acquisition terms, preferred stock features, dividend policies, and new credit facilities. For those researching the historical CCLDP preferred stock and its conversion, these filings offer the official record of the company’s decisions and the terms governing its preferred and common equity.
CareCloud, Inc. reported that Director Cameron Munter had 7,500 restricted stock units vest and convert into common stock on 08/08/2025 under the companys Amended and Restated Equity Incentive Plan without payment by the reporting person.
After the vesting and conversion, Munter is reported to beneficially own 189,000 shares of common stock and to hold 40,000 restricted stock units (derivative securities) remaining. The Form 4 was signed by Norman Roth as attorney-in-fact for Cameron Munter.
Anne Busquet, a director of CareCloud, Inc. (CCLD), reported that 7,500 restricted stock units vested and converted into common stock on 08/08/2025. The filing states these shares were issued under the Company's Amended and Restated Equity Incentive Plan and were acquired without payment.
The Form 4 shows the transaction recorded with code M (conversion upon vesting) and reports her direct beneficial ownership following the transaction as 281,388 common shares. Table II also reports 40,000 derivative securities beneficially owned following the reported transactions. The form is signed by attorney-in-fact Norman Roth on 08/08/2025.
CareCloud, Inc. (CCLD) director John N Daly converted 7,500 restricted stock units (RSUs) into common stock on 08/08/2025 under the Company’s Amended and Restated Equity Incentive Plan. The shares issued upon vesting were acquired without payment by the reporting person.
Following the reported transaction Mr. Daly beneficially owns 76,750 shares of common stock directly and is shown as beneficial owner of 40,000 derivative securities (restricted stock units). The Form 4 discloses a routine equity compensation vesting and conversion into common shares.
CareCloud director Bill Korn had 7,500 restricted stock units vest and convert into common stock on 08/08/2025 under the company’s Amended and Restated Equity Incentive Plan without payment by the reporting person.
The conversion added 7,500 shares to his direct holdings, bringing his total reported direct beneficial ownership to 197,883 shares, while his reported derivative holdings following the transaction were 40,000 RSU-equivalent securities. The filing records this routine equity compensation event for a director and documents the change in beneficial ownership.
Lawrence S. Sharnak, a director of CareCloud, Inc., had 7,500 restricted stock units vest and convert into 7,500 shares of common stock on 08/08/2025 under the company's Amended and Restated Equity Incentive Plan. The filing states the shares and the underlying units were issued without payment by the reporting person. After the reported transaction the Form 4 shows 114,000 shares of common stock beneficially owned and 40,000 derivative securities (restricted stock units) reported as beneficially owned, both in a direct ownership form.
FAQ
What is the current stock price of Carecloud (CCLDP)?
